Jagsonpal Pharmaceuticals Market Cap

Jagsonpal Pharmaceuticals has a market cap or net worth of 14.11 billion as of May 11, 2026. Its market cap has decreased by -6.59% in one year.

Market Cap

14.11B

Enterprise Value

13.13B

Revenue

2.87B

Ranking

n/a

PE Ratio

33.29

Stock Price

208.90

Market Cap Chart

Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 14.11B, a decrease of -20.00%. That is a compound annual growth rate of -0.85%.

Market Cap History

Date	Market Cap	% Change
May 11, 2026	14.11B	9.66%
Dec 31, 2025	12.86B	-20.68%
Dec 31, 2024	16.22B	58.61%
Dec 29, 2023	10.22B	4.69%
Dec 30, 2022	9.77B	108.36%
Dec 31, 2021	4.69B	150.03%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Innova Captab	50.11B
RPG Life Sciences	40.74B
Orchid Pharma	34.59B
Solara Active Pharma Sciences	25.31B
Indoco Remedies	21.04B
Windlas Biotech	17.37B
Beta Drugs	13.35B
Sakar Healthcare	12.14B

Market Cap Rankings